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Abstract: Following a hypothesis developed in an
earlier paper, here it is discussed how deviations of
blood pH from the normal range (namely states of
acidemia) together with high blood levels of free
fatty acids (FFA) may offer a rationale for many
important risk factors for cardiovascular diseases
(CVD) by shaping a context for formation of fatty
acid micelles and vesicles with an acidic core, which
fuse with the endothelia, disrupt vital cell processes,
and thereby may initiate atherosclerotic plaque for-
mation. Acidemia may arise primarily from dysreg-
ulation of the systemic buffers that control blood
pH, chronic diseases of kidneys and lungs, inappro-
priate diet, or may be induced by some common
drugs. The level of free fatty acids may be increased
and maintained high by chronic stress, and adrener-
gic shocks. Elevated concentrations of blood FFA in
a context of acidemia allow to understand important
cardiovascular aspects: the increased risk of
menopausal women, the protective effects of physi-
cal exercise, the changes in vascular behavior char-
acteristic of metabolic acidosis/acidemia, the role of
diet in the pH balance, on how some known medi-
cines like metformin, steroids, NSAIDS, proton
pump inhibitors, and calcium supplements may
influence CVD risk, and an explanation is offered
for the role of statins. [Discovery Medicine 23(126):183-
188, March 2017]
Introduction
In an earlier paper (Reis, 2016) an interpretive frame-
work was proposed that provides a rationale for many
well-known features of cardiovascular diseases (CVD).
In that paper it was discussed how acidemia together
with high blood levels of free fatty acids (FFA) may
shape a context for formation of fatty acid micelles and
vesicles with an acidic core, which fuse with the
endothelia, disrupt vital cell processes, and may initiate
atherosclerotic plaque formation. The same process was
proposed to play a role in acute events, namely heart
attacks and thromboembolic strokes. It was also shown
how this interpretative context is backed by a broad
body of literature published in the last decades.
In fact, some striking features of CVD hardly find a
rationale within the current views of CVD develop-
ment. For instance, patients may develop angina and
myocardial ischemia with clean coronaries (Abdelghani
et al., 2015; Baroldi and Silver, 2004). On the other
hand, on the basis of observations made during autop-
sies, some cardiovascular pathologists have sustained
that blockage of coronary arteries by thrombus is an
effect secondary to the heart attack (Baroldi and Silver,
2004). Some others advocate that atherosclerotic
plaques are caused by a single injurious agent that shall
be very different from the traditionally alleged ones
(Frink, 2002).
The possible role of the interplay between acidemia and
FFA on CVD was reviewed and discussed (Reis, 2016).
Because it is known that blood pH in normal conditions
is tightly regulated (Kellum, 2000) (namely though the
systemic buffers) little attention is usually paid to small
deviations from the normal range (7.38-7.42). Yet, as
stated by Pizzorno (2015): “a growing body of research
has documented not only that acidosis is a real phenom-
enon, but that it is now known to contribute to a wide
range of diseases.” Moreover, metabolic acidosis is
often asymptomatic, or may present as fatigue, anorex-
ia, confusion, tachycardia, tachypnea, and dehydration
(Pizzorno, 2015). Metabolic acidosis, and thus blood
acidemia, can have many causes, though is more often
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due to kidney dysfunction (Kraut and Madias, 2016) or
induced by uptake of medications and drugs (Liamis, et
al., 2010), or even by diet (Adeva and Souto, 2011).
By itself, a state of acidemia might not cause CVD.
However, acidemia may dramatically change the
behavior of blood FFA: at slightly lower pH, FFA are
fully protonated and form an oil phase, while at higher
pH they are fully deprotonated and form FFA micelles
and vesicles (Hentrich and Szostak, 2014; Markvoort et
al., 2010; Morigaki and Walde, 2007; Chen and
Szostak, 2004). Hyperventilation as a compensatory
mechanism that develops to restore normal pH levels
causes pH imbalances in the blood flowing from the
lungs to the heart. It was proposed that if a state of
acidemia occurs together with high blood concentration
of FFA, micelles and fatty acid (FA) vesicles with an
acidic core may develop, fuse with the endothelia, and
initiate plaque formation. The process of micelle and
FA vesicle formation, and fusion with the endothelia, is
described in the biomedical literature, and occurs in
special conditions of local blood pH imbalance (see
Reis, 2016). The blood concentration of FFA may
increase mainly as a consequence of elevated cortisol
levels, or adrenergic shocks (Newsholme and Leech,
2010).
In what follows we analyze some common risk factors
of CVD that may find a rationale within the proposed
interpretive framework (Reis, 2016). We also offer
explanations for the increase in the risk of CVD in peo-
ple taking some well-known drugs. It should be noted
that risk is here understood in the sense of the existence
of any association (causal or not) between a particular
health condition and CVD.
Blood pH and Free Fatty Acids
Blood pH is tightly regulated by several mechanisms in
the body, which may be divided into 3 groups: (i)
buffering activity; (ii) Excretion of acids and bases
through sweat, stomach, urine, and feces; and (iii)
removal of carbon dioxide by the lungs.
Buffers, which consist of a weak acid and a weak base
at equilibrium with each other, work by taking the extra
protons (H+) and making the base component of the
buffer to react with the protons to turn into the conju-
gate acid therefore neutralizing most of the extra pro-
tons. Important buffers are the bicarbonate buffer sys-
tem that promotes the interconversion of blood bicar-
bonate and protons to carbon dioxide and water, and the
phosphate and protein buffer systems that operate in the
internal fluid of all cells (Das, 2005). Bones, which are
the largest alkaline reserve in the body, also represent
an important buffer. Bone buffering operates through
the uptake of H+ from the blood with release of bone
Ca2+ to the blood, or by adsorption of HCO3- onto the
crystal surfaces of bone minerals (Lemann et al., 2003;
Krieger et al., 2004).
Circulating FFA mainly originate from lipolysis in the
adipose tissue, and their concentration in plasma is usu-
ally in the range 100 mmol/L-1 mmol/L (Frayn, 2005).
Hyperadrenergic states, namely those occurring as a
response to catecholamine stimulus, increase plasma
FFA levels markedly (Newsholme and Leech, 2010;
Frayn, 2005).
In fact, some lines of evidence exist that point to the
association of FFA, and specifically FA micelles and
vesicles, with CVD (Srinivasan, 2012; Bobryshev et
al., 2007, Pilz et al., 2007; 2006). Vesicle remnants
were found in atherosclerotic plaques (Bobryshev et al.,
2007, Pilz et al., 2007), and it is known that in case they
cause damage to the endocardium, the myocardial func-
tion is compromised in respect to contractibility and
electric activity (Brutsaert et al., 1988).
Cardiopathologists who analyzed post-mortem lesions
in the heart [e.g., contraction band necrosis (Baroldi
and Silver, 2004)] have pointed out that they do not
seem to be caused by usual injurious factors (Frink,
2002). Frink put forward the hypothesis that a special
injurious agent should initiate the process of atheroscle-
rotic plaque formation. In our hypothesis the role of
Frink’s “infectious agent” (and toxins) is played by the
FFA vesicles with an acidic core.
In the following we show how the hypothesis of elevat-
ed FFA levels in the context of acidemia, leading to FA
vesicle formation, offers explanations for major CVD
risk factors.
Understanding CVD Risk Factors in the Light of the
Proposed Hypothesis
In the proposed framework, boost of blood FFA con-
centration in a state of acidemia forms the context for
increased risk of CVD events (Reis, 2016). Therefore,
in such context CVD risk must increase with dysregu-
lation of the main mechanisms that tightly control blood
pH, i.e., the systemic buffers, kidney function, and res-
piratory function. In general, the proper functioning of
these mechanisms is affected by many diseases, uptake
of drugs, inappropriate diet, and age. Moreover, contin-
uous stress increases and keeps high FFA levels in the
blood, while adrenergic shocks may suddenly raise
these levels (Newsholme and Leech, 2010).
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Elevated blood levels of FFA
Some studies (e.g., Srinivasan, 2012; Pilz et al., 2006)
have associated raised blood levels of FFA with CVD.
Increase in plasma catecholamine levels, with the con-
sequent increase in blood FFA concentration, has been
associated with myocardial infarction and stroke
(Hachinski et al., 1986). Moreover, events of myocar-
dial infarction (MI) and sudden cardiac death (SCD)
peak in the morning (Muller et al., 1987). Coincidently,
both the blood levels of cortisol and FFA also peak in
the early morning (Portaluppi and Lemmer, 2007;
Muller et al., 1987). SCD and MI events have also been
found to markedly increase after catastrophes, situa-
tions that are conducive to the occurrence of surges of
plasma FFA [e.g., war (Meisel et al., 1991), earthquake
(Leor et al., 1996), or sport events (Kirkup and Merrick,
2003)]. In effect, increased plasma levels of both norep-
inephrine and epinephrine were found in patients at the
time of MI events (Slavíková, 2007; Remme et al.,
1987; Schomig, 1988). To the knowledge of this author
no published study addresses the simultaneous meas-
urement of blood pH and the concentrations of FFA.
Although strong association was found between elevat-
ed concentrations of FFA and CVD events, we specu-
late that a stronger association would emerge if only
CVD events in a context of acidemia were considered.
Aging, and the decline of the systemic buffers, and renal
and respiratory functions
It is known that the systemic pH buffers decline with
age (Amodu and Abramowitz, 2013; Frassetto and
Sebastian, 1996). Similar decline occurs with the renal
function (Weinstein and Anderson, 2010; Frassetto et
al., 1996), and the respiratory function (Sharma and
Goodwin, 2006). Therefore, acidemia states are increas-
ingly likely to occur with aging. Some authors (e.g.,
Pizzorno, 2015; Amodu and Abramowitz, 2013) point-
ed out that subclinical acidosis increases with age, and
is very common in the elderly, whilst on the other hand,
age is a well established factor for CVD (Mozaffarian et
al., 2015). Within the proposed framework (Reis, 2016)
we are able to associate aging with CVD due to the fact
that decline of the mechanisms that control blood pH
leads to increase of the frequency of acidemia states
with aging, and therefore forms one of the conditions of
the context for CVD development.
Statistics shows that the frequency of CVD in pre-
menopausal women is lower than in males of the same
age (Mozaffarian et al., 2015) but greatly increases in
menopause, age at which it reaches the same pattern of
CVD frequency in males. In fact, because during the
women’s fertile age the slightly alkaline environment in
the uterus is vital for conception and fetus development,
its pH must be tightly controlled (Dale et al., 1998). On
the other hand, a study (animal model) (Marcus, 1965)
showed that estrogens turn uterus more alkaline, whilst
in premenopausal women they attenuate blood pres-
sure, glucocorticoid, and catecholamine responses to
psychological stress (Komesaroff, 1999; Rosano and
Panina, 1999). The fact that estrogens prevent devia-
tions from the normal blood pH, and attenuate the effect
of catecholamines might explain the lower incidence of
CVD among women during their fertile age.
Furthermore, as referred above, because bones are the
greatest alkaline reserve in the body, a sign that in
menopausal women blood acidemia is likely to be fre-
quent is the increased loss of bone mass (osteoporosis),
namely via the resorption of calcium in the blood
(Pizzorno, 2015; Krieger et al., 2004; Lemann et al.,
2003).
The decline of the respiratory function with age (name-
ly in smokers and other people affected by environmen-
tal pollution), which is key to regulate blood pH home-
ostasis, also contributes to CVD risk (Reis, 2016;
Sharma and Goodwin, 2006).
On the other hand, the pH buffering capacity can be
increased through physical exercise (Wasserman et al.,
2012; Röcker et al., 1994) thereby explaining why
moderate physical exercise is a factor protective against
CVD.
As an additional outcome of the present framework,
hyperventilation as part of the process compensatory to
acidemia described (Reis, 2016) enables the under-
standing the changes in the vascular behavior that are
characteristic of metabolic acidosis/acidemia, namely:
(i) peripheral arteriolar vasodilatation; (ii) venocon-
striction of peripheral veins; and (iii) vasoconstriction
of pulmonary arteries (Brandis, 2017). Such sequence
may be understood as follows: (i) in an acidemia state
the blood coming from the heart is more alkaline (Reis,
2016), therefore most of calcium ions are bound to
albumin, hence its concentration in the blood is low
thereby allowing vasodilatation (Widmaier et al.,
2010); (ii) as the blood bathes tissues in the state of aci-
dosis its pH drops, hence calcium ions are released from
albumin binding sites, and consequently are available
for inducing vein constriction; and (iii) the lower pH
blood with increased level of calcium ions is transport-
ed to the right atrium and ventricle, and then to the
lungs, thereby explaining constriction of pulmonary
arteries.
The vasoconstriction (peripheral veins and pulmonary
arteries) characteristic of acidemia certainly plays a role
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in hypertension, which is an established risk for CVD.
Cholesterol and statins
In the framework discussed here, the role of cholesterol
as a primary injurious agent is not addressed, but its
function is discussed as part of the repairing mechanism
put into action after the endothelial injury. Interestingly,
the model of arterial occlusion by thrombus with origin
in plaque rupture as the primary cause of heart attack
has been challenged by the observations made in autop-
sy showing that heart attacks and myocardial infarction
occur even in the absence of thrombus occluding the
coronary arteries (e.g., Abdelghani et al., 2015; Baroldi
and Silver, 2004; Silver et al., 1980; Roberts, 1972),
while acute coronary occlusions may occur without
concomitant MI (Baroldi and Silver, 2004).
Some authors have pointed out that the beneficial
action of statins with respect to CVD prevention and
management -- though many questions have been
raised about statin side effects (Hippisley-Cox and
Coupland, 2010) -- is due to pleiotropic effects other
than cholesterol lowering (e.g., Nordmann and Briel,
2012). In fact, in respect to CVD as it is analyzed in the
proposed framework, statins produce mixed results:
while they contribute to acidosis (Liamis et al., 2010;
Neale et al., 2004; Goli et al., 2002) they also lower
plasma FFA concentrations (Sahebkar et al., 2016). As
discussed above, peaks of FFA are key to CVD devel-
opment, and thereby the lowering of plasma FFA levels
may be the reason for the protective effect of statins.
Diet
Diet may contribute to the acid load in the body. Animal
proteins and cereal grains increase the body acid load,
while fruits and vegetables turn it more alkaline
(Amodu and Abramowitz, 2013; Adeva and Souto,
2011). Sugar in the diet also generates acid in the gas-
trointestinal tract (Halperin and Kamel, 1996). In mod-
ern societies diet is generally high in meat, cereal
derived products, and sugar, which promote acidity
and, within the present framework, thereby the ground
for CVD development. Some authors have pointed out
the increase in acid load caused by shift to the modern
diet, and namely the pathophysiologic effects of the
post-agricultural inversion of the potassium-to-sodium
and base-to-chloride ratios in the human diet (Sebastian
et al., 2002; Frassetto et al., 2001). On the other hand,
many studies have evinced the protective effect of the
Mediterranean diet (alkalinity promoter) against CVD
(Estruch et al., 2013).
Uptake of common drugs
Taking of some medications may affect the acid-base
balance (Liamis et al., 2010) and according to the pro-
posed framework may thus affect the risk of CVD.
Beyond known drugs that have been associated with
acidosis, such as metformin (the most prescribed antidi-
abetic drug in the world) (Liamis et al., 2010), steroids
(Liamis et al., 2010; Hulter et al., 1980), and NSAIDS
(Hunter et al., 2011; Liamis et al., 2010), other com-
mon drugs have been associated with the increase in
CVD risk. For instance, proton pump inhibitors (PPI)
have been associated with increased CVD risk (Shah et
al., 2015). This fact is also understood within the pres-
ent framework as PPI, by inhibiting secretion of pro-
tons into the stomach, block one of the ways by which
the body gets rid of intercellular acid. Also calcium
supplementation has been found to increase MI risk (Li
et al., 2010). Actually, excessive calcium concentration
in the blood may offset the buffering action of bone,
because calcium ions release from bone (and thus
uptake of protons in bone) is counteracted by the strong
concentration of calcium ions in the blood.
Conclusions
The proposed interpretive framework in which states of
acidemia together with high blood levels of free fatty
acids (FFA) shape a context for cardiovascular diseases
(CVD) offers a rationale for many well-known features
of CVD.
The published literature shows that mild acidemia
states are very common, mainly due to decline of sys-
temic buffers with aging, chronic kidney disease, respi-
ratory diseases, inappropriate diet, and drugs, at the
same time that adrenergic shocks that increase the
blood concentration of FFA are also common in modern
daily life. Associations between acidemia and increased
blood concentrations of free fatty acids, and cardiovas-
cular risk factors are also easily found in the literature.
Important CVD risk factors are analyzed, which con-
strue a rationale in the proposed framework.
Specifically, aging, protective factors, and the role of
some common drugs on CVD are addressed in relation
with blood pH, and in particular an explanation is
offered for the role of statins based on their ability to
reduce the blood concentration of free fatty acids.
The present study does not extensively cover all identi-
fied CVD risk factors. Analysis must proceed in order
to investigate if other CVD risk factors do fit in the pro-
posed context.
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